For: | Jing Z, Nan KJ, Hu ML. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. World J Gastroenterol 2005; 11(13): 1910-1916 [PMID: 15800979 DOI: 10.3748/wjg.v11.i13.1910] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i13/1910.htm |
Number | Citing Articles |
1 |
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, Jürgen Durner, Petra Stieber, Stefan Holdenrieder. Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-202
|
2 |
Zhen Yu, Ronglei Zhao. Inhibition of anaplastic lymphoma kinase promotes apoptosis and suppresses proliferation in human hepatocellular carcinoma. Anti-Cancer Drugs 2018; 29(6): 513 doi: 10.1097/CAD.0000000000000616
|
3 |
Y Zhang, J Dai, H Deng, H Wan, M Liu, J Wang, S Li, X Li, H Tang. miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop. British Journal of Cancer 2015; 112(2): 365 doi: 10.1038/bjc.2014.593
|
4 |
Liqiang Zhong, Sihao Yang, Yuming Jia, Kaijian Lei. Inhibition of cyclin‐dependent kinase 7 suppresses human hepatocellular carcinoma by inducing apoptosis. Journal of Cellular Biochemistry 2018; 119(12): 9742 doi: 10.1002/jcb.27292
|
5 |
Stephen A. Geller, Deepti Dhall, Randa Alsabeh. Application of Immunohistochemistry to Liver and Gastrointestinal Neoplasms: Liver, Stomach, Colon, and Pancreas. Archives of Pathology & Laboratory Medicine 2008; 132(3): 490 doi: 10.5858/2008-132-490-AOITLA
|
6 |
Ofer Ben-Izhak, Sharon Akrish, Shlomit Gan, Rafael M. Nagler. p27 and salivary cancer. Cancer Immunology, Immunotherapy 2009; 58(3): 469 doi: 10.1007/s00262-008-0547-9
|
7 |
Yabo Ma, Changzheng Du, Xianguo Xie, Yan Zhang, Chao Wang, Jinrui Xu, Guoliang Xia, Yi Yang. To explore the regulatory role of Wnt/P53/Caspase3 signal in mouse ovarian development based on LFQ proteomics. Journal of Proteomics 2023; 272: 104772 doi: 10.1016/j.jprot.2022.104772
|
8 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
9 |
Jan P. Berg, Qi Zhou, Kai Breuhahn, Peter Schirmacher, Mohini A. Patil, Xin Chen, Nico Schäfer, Tobias T. Höller, Hans-Peter Fischer, Reinhard Büttner, Ines Gütgemann. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma. Human Pathology 2007; 38(11): 1621 doi: 10.1016/j.humpath.2007.03.007
|
10 |
Dong-Yan Shen, Zan-Xi Fang, Pan You, Ping-Guo Liu, Fen Wang, Chun-Ling Huang, Xiao-Bin Yao, Zi-Xuan Chen, Zhong-Ying Zhang. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver International 2010; 30(1): 119 doi: 10.1111/j.1478-3231.2009.02106.x
|
11 |
Azza E El Bassiouny, Mona M Nosseir, Mona K Zoheiry, Noha A Ameen, Ahmed M Abdel-Hadi, Ibrahim M Ibrahim, Suher Zada, Abdel-Hakeem Saad El-Deen, Nora E El-Bassiouni. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World Journal of Hepatology 2010; 2(1): 32-41 doi: 10.4254/wjh.v2.i1.32
|
12 |
Yohei Saito, Yoshikazu Kuwahara, Yumi Yamamoto, Masatoshi Suzuki, Manabu Fukumoto, Fumihiko Yamamoto. ddY Mice Fed 10% Fat Diet Exhibit High p27KIP Expression and Delayed Hepatocyte DNA Synthesis During Liver Regeneration. Metabolic Syndrome and Related Disorders 2018; 16(6): 305 doi: 10.1089/met.2017.0131
|
13 |
Yangyang Miao, Shunyi Wang, Jiahao Zhang, Huanxiang Liu, Chi Zhang, Shengjie Jin, Dousheng Bai. Strategic advancement of E3 ubiquitin ligase in the management of hepatocellular carcinoma. Medical Oncology 2024; 41(7) doi: 10.1007/s12032-024-02411-8
|
14 |
Gang Li, Xiaojia Xiong. MicroRNAs and hepatitis viruses. Frontiers of Medicine in China 2009; 3(3): 265 doi: 10.1007/s11684-009-0055-0
|
15 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
|
16 |
HUAN ZHANG, YUBO HOU, SENJIE LIN. Isolation and Characterization of Proliferating Cell Nuclear Antigen from the Dinoflagellate Pfiesteria piscicida. Journal of Eukaryotic Microbiology 2006; 53(2): 142 doi: 10.1111/j.1550-7408.2005.00085.x
|
17 |
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, Jürgen Durner, Petra Stieber, Stefan Holdenrieder. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy. Tumor Biology 2012; 33(1): 33 doi: 10.1007/s13277-011-0237-7
|
18 |
Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(8): 1175-1181 doi: 10.3748/wjg.v12.i8.1175
|
19 |
Ifeanyi G. Eke, Chukwunonso K. Ezeasor, Aruh O. Anaga. Vitamin D supplementation enhanced oral glucose tolerance in normoglycemic rats and insulin sensitivity in rats fed high fat emulsion. Comparative Clinical Pathology 2019; 28(2): 383 doi: 10.1007/s00580-019-02904-3
|
20 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3173 doi: 10.1007/978-3-319-26956-6_174
|
21 |
Mary Chatterjee, Subhadeep Das, Kaushik Roy, Malay Chatterjee. Overexpression of 5‐lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12‐dimethylbenz(α)anthracene‐induced rat mammary carcinogenesis. Molecular Carcinogenesis 2013; 52(5): 359 doi: 10.1002/mc.21858
|
22 |
Olca Basturk, Alton B. Farris, N. Volkan Adsay. Diagnostic Immunohistochemistry. 2011; : 541 doi: 10.1016/B978-1-4160-5766-6.00019-4
|
23 |
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, Jürgen Durner, Petra Stieber, Stefan Holdenrieder. Circulating Nucleic Acids in Plasma and Serum. 2010; : 73 doi: 10.1007/978-90-481-9382-0_10
|